a-495 Search Results


osimertinib  (Alomone Labs)
92
Alomone Labs osimertinib
Fig. 3 MRAS and HEG1 are highly expressed in <t>osimertinib-resistant</t> cells and tissues. A The Venn plot of DEGs from the merged dataset and six datasets. B The heatmap of MRAS and HEG1 in osimertinib-sensitive and resistant LUAD cells from six GEO datasets. C Bare mean of counts of MRAS and HEG1 from the online RNA-seq data [9]. D IHC analysis of MRAS in tumor biopsies from LUAD patients (left panel). The DAB positive signals were analyzed by the Halo data analysis system (right panel). E IHC analysis of HEG1 in tumor biopsies from LUAD patients (left panel). The DAB positive signals were analyzed by the Halo data analysis system (right panel). F-G The Kaplan–Meier plots of the survival analysis of LUAD patient data from the GSE14814 dataset (N = 265)
Osimertinib, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/a-495/AZD-1332/pm39560891-152-0-13
Average 92 stars, based on 1 article reviews
osimertinib - by Bioz Stars, 2026-08
92/100 stars
  Buy from Supplier
a 495-nm longpass filter  (Ocean Insight)
90
Ocean Insight a 495-nm longpass filter
Fig. 3 MRAS and HEG1 are highly expressed in <t>osimertinib-resistant</t> cells and tissues. A The Venn plot of DEGs from the merged dataset and six datasets. B The heatmap of MRAS and HEG1 in osimertinib-sensitive and resistant LUAD cells from six GEO datasets. C Bare mean of counts of MRAS and HEG1 from the online RNA-seq data [9]. D IHC analysis of MRAS in tumor biopsies from LUAD patients (left panel). The DAB positive signals were analyzed by the Halo data analysis system (right panel). E IHC analysis of HEG1 in tumor biopsies from LUAD patients (left panel). The DAB positive signals were analyzed by the Halo data analysis system (right panel). F-G The Kaplan–Meier plots of the survival analysis of LUAD patient data from the GSE14814 dataset (N = 265)
A 495 Nm Longpass Filter, supplied by Ocean Insight, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/a-495/a+495+nm+longpass+filter/10__1007_slash_s00216___019___01848___5-63-2-12
Average 90 stars, based on 1 article reviews
a 495-nm longpass filter - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
digital camera canon power shot a495  (Canon inc)
90
Canon inc digital camera canon power shot a495
Fig. 3 MRAS and HEG1 are highly expressed in <t>osimertinib-resistant</t> cells and tissues. A The Venn plot of DEGs from the merged dataset and six datasets. B The heatmap of MRAS and HEG1 in osimertinib-sensitive and resistant LUAD cells from six GEO datasets. C Bare mean of counts of MRAS and HEG1 from the online RNA-seq data [9]. D IHC analysis of MRAS in tumor biopsies from LUAD patients (left panel). The DAB positive signals were analyzed by the Halo data analysis system (right panel). E IHC analysis of HEG1 in tumor biopsies from LUAD patients (left panel). The DAB positive signals were analyzed by the Halo data analysis system (right panel). F-G The Kaplan–Meier plots of the survival analysis of LUAD patient data from the GSE14814 dataset (N = 265)
Digital Camera Canon Power Shot A495, supplied by Canon inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/a-495/digital+camera+canon+powershot+a495/pmc06580938-74-99-100
Average 90 stars, based on 1 article reviews
digital camera canon power shot a495 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
ep a 495.056  (Cerestar USA Inc)
90
Cerestar USA Inc ep a 495.056
Fig. 3 MRAS and HEG1 are highly expressed in <t>osimertinib-resistant</t> cells and tissues. A The Venn plot of DEGs from the merged dataset and six datasets. B The heatmap of MRAS and HEG1 in osimertinib-sensitive and resistant LUAD cells from six GEO datasets. C Bare mean of counts of MRAS and HEG1 from the online RNA-seq data [9]. D IHC analysis of MRAS in tumor biopsies from LUAD patients (left panel). The DAB positive signals were analyzed by the Halo data analysis system (right panel). E IHC analysis of HEG1 in tumor biopsies from LUAD patients (left panel). The DAB positive signals were analyzed by the Halo data analysis system (right panel). F-G The Kaplan–Meier plots of the survival analysis of LUAD patient data from the GSE14814 dataset (N = 265)
Ep A 495.056, supplied by Cerestar USA Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/a-495/ep+a+495+056/us08383134-60-19-4
Average 90 stars, based on 1 article reviews
ep a 495.056 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

Image Search Results


Fig. 3 MRAS and HEG1 are highly expressed in osimertinib-resistant cells and tissues. A The Venn plot of DEGs from the merged dataset and six datasets. B The heatmap of MRAS and HEG1 in osimertinib-sensitive and resistant LUAD cells from six GEO datasets. C Bare mean of counts of MRAS and HEG1 from the online RNA-seq data [9]. D IHC analysis of MRAS in tumor biopsies from LUAD patients (left panel). The DAB positive signals were analyzed by the Halo data analysis system (right panel). E IHC analysis of HEG1 in tumor biopsies from LUAD patients (left panel). The DAB positive signals were analyzed by the Halo data analysis system (right panel). F-G The Kaplan–Meier plots of the survival analysis of LUAD patient data from the GSE14814 dataset (N = 265)

Journal: Discover oncology

Article Title: Aberrant expression of MRAS and HEG1 as the biomarkers for osimertinib resistance in LUAD.

doi: 10.1007/s12672-024-01552-6

Figure Lengend Snippet: Fig. 3 MRAS and HEG1 are highly expressed in osimertinib-resistant cells and tissues. A The Venn plot of DEGs from the merged dataset and six datasets. B The heatmap of MRAS and HEG1 in osimertinib-sensitive and resistant LUAD cells from six GEO datasets. C Bare mean of counts of MRAS and HEG1 from the online RNA-seq data [9]. D IHC analysis of MRAS in tumor biopsies from LUAD patients (left panel). The DAB positive signals were analyzed by the Halo data analysis system (right panel). E IHC analysis of HEG1 in tumor biopsies from LUAD patients (left panel). The DAB positive signals were analyzed by the Halo data analysis system (right panel). F-G The Kaplan–Meier plots of the survival analysis of LUAD patient data from the GSE14814 dataset (N = 265)

Article Snippet: Osimertinib (Cat. S7297) and AZD1332 (Cat. A-495) were purchased from Selleck (USA) and Alomone Labs Vol:. (1234567890) (Israel), respectively.

Techniques: RNA Sequencing